Watz, H., Rickard, K., Rheault, T., Bengtsson, T., & Singh, D. (2020). Symptom Improvement Following Treatment with the Inhaled Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine in Patients with Moderate to Severe COPD – A Detailed Analysis. Int J Chron Obstruct Pulmon Dis.
Chicago Style citaatWatz, Henrik, Kathleen Rickard, Tara Rheault, Thomas Bengtsson, en Dave Singh. "Symptom Improvement Following Treatment With the Inhaled Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine in Patients With Moderate to Severe COPD – A Detailed Analysis." Int J Chron Obstruct Pulmon Dis 2020.
MLA citatieWatz, Henrik, et al. "Symptom Improvement Following Treatment With the Inhaled Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine in Patients With Moderate to Severe COPD – A Detailed Analysis." Int J Chron Obstruct Pulmon Dis 2020.